Coronavirus Update: Sanofi And GSK’s Vaccine Suffers Setback

Plus: Pfizer On Track In US, But Needs More Time In India

 
• By Scrip Team
  
Sanofi - GSK
The companies believe the vaccine could be authorized and ready for use by Q4 2021, approximately a six month delay to previous timelines.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip